Cui J, Chen M, Zhang L, Huang S, Xiao F, Zou L
Cancer Innov. 2023; 1(3):197-206.
PMID: 38089761
PMC: 10686110.
DOI: 10.1002/cai2.28.
Zhang B, Zhang H, Wang Z, Cao H, Zhang N, Dai Z
CNS Neurosci Ther. 2023; 30(4):e14500.
PMID: 37953502
PMC: 11017455.
DOI: 10.1111/cns.14500.
Martinez de Estibariz I, Jakjimovska A, Illarregi U, Martin-Guerrero I, Gutierrez-Camino A, Lopez-Lopez E
Cancers (Basel). 2023; 15(19).
PMID: 37835380
PMC: 10571996.
DOI: 10.3390/cancers15194686.
Pisignano G, Michael D, Visal T, Pirlog R, Ladomery M, Calin G
Oncogene. 2023; 42(38):2783-2800.
PMID: 37587333
PMC: 10504067.
DOI: 10.1038/s41388-023-02780-w.
Garcia-Rodriguez J, Korsgaard U, Ahmadov U, Jarlstad Olesen M, Dietrich K, Hansen E
Cancer Res. 2023; 83(20):3340-3353.
PMID: 37477923
PMC: 10570686.
DOI: 10.1158/0008-5472.CAN-23-0748.
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas.
Katsushima K, Pokhrel R, Mahmud I, Yuan M, Murad R, Baral P
Acta Neuropathol Commun. 2023; 11(1):38.
PMID: 36899402
PMC: 10007801.
DOI: 10.1186/s40478-023-01521-0.
Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer.
Pitolli C, Marini A, Sette C, Pagliarini V
Int J Mol Sci. 2022; 23(5).
PMID: 35269953
PMC: 8911335.
DOI: 10.3390/ijms23052811.
Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.
Lee B, Mahmud I, Pokhrel R, Murad R, Yuan M, Stapleton S
Acta Neuropathol Commun. 2022; 10(1):25.
PMID: 35209946
PMC: 8867780.
DOI: 10.1186/s40478-022-01326-7.
The emerging roles of circRNAs in cancer and oncology.
Kristensen L, Jakobsen T, Hager H, Kjems J
Nat Rev Clin Oncol. 2021; 19(3):188-206.
PMID: 34912049
DOI: 10.1038/s41571-021-00585-y.
M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way.
Li K, Peng Z, Gao S, Wang Q, Wang R, Li X
J Exp Clin Cancer Res. 2021; 40(1):325.
PMID: 34656164
PMC: 8520306.
DOI: 10.1186/s13046-021-02137-9.
The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas.
Li K, Ma L, Sun Y, Li X, Ren H, Tang S
Sci Rep. 2021; 11(1):18587.
PMID: 34545132
PMC: 8452722.
DOI: 10.1038/s41598-021-98131-4.
MicroRNAs and Stem-like Properties: The Complex Regulation Underlying Stemness Maintenance and Cancer Development.
Divisato G, Piscitelli S, Elia M, Cascone E, Parisi S
Biomolecules. 2021; 11(8).
PMID: 34439740
PMC: 8393604.
DOI: 10.3390/biom11081074.
